Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

WeiDong Han

Showing results (321-330 of 371) with videos related to

Pageof 38
Sort By:
European Journal of Immunology|March 11, 2015
Substrate stiffness regulates B-cell activation, proliferation, class switch, and T-cell-independent antibody responses in vivoYingyue Zeng, Junyang Yi, Zhengpeng Wan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2021
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade MonotherapyChunmeng Wang, Yang Liu, Liang Dong, et al.
Biochemical and Biophysical Research Communications|June 18, 2013
Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes ratsHaojie Hao, Jiejie Liu, Jing Shen, et al.
Cancer Science|August 27, 2021
Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinomaHongming Pan, Huanqing Cheng, Huina Wang, et al.
Nature Communications|August 13, 2024
Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trialLiang Dong, Zhi Cao, Meixia Chen, et al.
Frontiers in Molecular Biosciences|July 26, 2021
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8<sup>+</sup> T Cells in Chinese Advanced Non-Small-Cell Lung Cancer Patients Treated With the Anti-PD-L1 AntibodyJin Sheng, Huadi Wang, Xiao Liu, et al.
The Journal of Clinical Investigation|May 12, 2015
MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipidsXianghui Fu, Bingning Dong, Yan Tian, et al.
Cell Reports. Medicine|December 10, 2024
Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic stateXingying Zhang, Chenze Zhang, Shan Lu, et al.
International Journal of Cancer|April 18, 2018
Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancerMeixia Chen, Jing Nie, Yang Liu, et al.
Journal of Hematology & Oncology|April 5, 2020
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Pageof 38

Showing results (321-330 of 371) with videos related to

Sort By:
Pageof 38
European Journal of Immunology|March 11, 2015
Substrate stiffness regulates B-cell activation, proliferation, class switch, and T-cell-independent antibody responses in vivoYingyue Zeng, Junyang Yi, Zhengpeng Wan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2021
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade MonotherapyChunmeng Wang, Yang Liu, Liang Dong, et al.
Biochemical and Biophysical Research Communications|June 18, 2013
Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes ratsHaojie Hao, Jiejie Liu, Jing Shen, et al.
Cancer Science|August 27, 2021
Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinomaHongming Pan, Huanqing Cheng, Huina Wang, et al.
Nature Communications|August 13, 2024
Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trialLiang Dong, Zhi Cao, Meixia Chen, et al.
Frontiers in Molecular Biosciences|July 26, 2021
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8<sup>+</sup> T Cells in Chinese Advanced Non-Small-Cell Lung Cancer Patients Treated With the Anti-PD-L1 AntibodyJin Sheng, Huadi Wang, Xiao Liu, et al.
The Journal of Clinical Investigation|May 12, 2015
MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipidsXianghui Fu, Bingning Dong, Yan Tian, et al.
Cell Reports. Medicine|December 10, 2024
Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic stateXingying Zhang, Chenze Zhang, Shan Lu, et al.
International Journal of Cancer|April 18, 2018
Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancerMeixia Chen, Jing Nie, Yang Liu, et al.
Journal of Hematology & Oncology|April 5, 2020
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Pageof 38